FDMT - 4D Molecular Therapeutics, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$33.00
DETAILS
HIGH:
$33.00
LOW:
$33.00
MEDIAN:
$33.00
CONSENSUS:
$33.00
UPSIDE:
283.72%
Profitability Ratios
| Ratio | Value |
|---|---|
| GP Margin | 91.1% |
| EBIT Margin | -187.2% |
| EBITDA Margin | -178.3% |
| Operating Margin | -187.2% |
| Pretax Margin | -164.4% |
| Cont. Ops Margin | -164.4% |
| Net Margin | -164.4% |
| Bottom Line Margin | -164.4% |
Liquidity Ratios
| Ratio | Value |
|---|---|
| Current Ratio | 9.39 |
| Quick Ratio | 9.39 |
| Solvency Ratio | -2.170 |
| Cash Ratio | 1.37 |
Valuation Ratios
| Ratio | Value |
|---|---|
| Price/Earnings |
-3.10
Peers avg: 19.5
|
| PEG Ratio | 0.17 |
| Forward PEG | 0.17 |
| Price/Book | 0.86 |
| Price/Sales | 5.10 |
| Price/FCF | -3.98 |
| Price/Op Cash Flow | -3.98 |
Debt Ratios
| Ratio | Value |
|---|---|
| Debt/Assets | 0.0378 |
| Debt/Equity | 0.0423 |
| Debt/Capital | 0.0406 |
| Long-Term Debt/Capital | 0.0303 |
| Financial Leverage | 1.12 |
Cash Flow Ratios
| Ratio | Value |
|---|---|
| Working Capital Turnover | 0.22 |
| Operating Cash Flow Ratio | -2.480 |
| Operating Cash Flow/Sales | -128.0% |
| Free Cash Flow/Operating Cash Flow | 100.0% |
Coverage Ratios
| Ratio | Value |
|---|---|
| Debt Service Coverage | -27.17 |
| Interest Coverage | 0.0000 |
| Short-Term Operating Cash Flow Coverage | -19.51 |
| Operating Cash Flow Coverage | -5.09 |
| Capital Expenditure Coverage | -203.51 |
| Dividend + Capital Expenditure Coverage | -203.51 |
Dividend Ratios
| Ratio | Value |
|---|---|
| Payout Ratio | 0.0000% |
| Dividend Yield | 0.0000% |
| Dividend Yield % | 0.0000% |
| Dividend Per Share | 0.0000 |
Per Share Ratios
| Ratio | Value |
|---|---|
| Revenue/Share | 1.47 |
| EPS | -2.419 |
| Debt/Share | 0.3696 |
| Cash/Share | 6.95 |
| Book Value/Share | 8.73 |
| Tangible BV/Share | 8.73 |
| Equity/Share | 8.73 |
| Operating Cash Flow/Share | -1.883 |
| Capital Expenditure/Share | 0.009 |
| FCF/Share | -1.883 |
Other Ratios
| Ratio | Value |
|---|---|
| Net Income/Earnings Before Tax | 1.000 |
| Earnings Before Tax/EBIT | 0.878 |
| Price/Fair Value | 0.86 |
| Debt/Market Cap | 0.0493 |
| Effective Tax Rate | 0.0% |
| Enterprise Value Multiple | -2.60 |